Drinking Sugary Sodas May Promote Aging at Cellular Level

This article originally appeared here.
Share this content:
Drinking Sugary Sodas May Promote Aging at Cellular Level
Drinking Sugary Sodas May Promote Aging at Cellular Level

(HealthDay News) -- Drinking sugar-sweetened sodas may affect cellular aging by shortening telomere length, according to research published online Oct. 16 in the American Journal of Public Health.

Cindy W. Leung, Sc.D., of the University of California in San Francisco, and colleagues conducted a cross-sectional analysis of the relationships between leukocyte telomere length and consumption of beverages, including sugar-sweetened beverages (SSBs), diet soda, and fruit juice, in a representative sample of 5,309 healthy adults, aged 20 to 65 years.

After adjustment for health-related and sociodemographic variables, the researchers found that consumption of sugar-sweetened soda was associated with shorter telomeres (b = −0.010; 95 percent confidence interval [CI], −0.020 to −0.001; P = 0.04). A marginal association was found between consumption of 100-percent fruit juice and longer telomeres (b = −0.016; 95 percent CI, −0.000 to 0.033; P = 0.05). No significant associations were found between consumption of diet sodas or noncarbonated SSBs and telomere length.

"Regular consumption of sugar-sweetened sodas might influence metabolic disease development through accelerated cell aging," the authors write.

Several authors are co-founders of Telomere Diagnostics, a telomere measurement company.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths